BACKGROUND: We determined the minimum threshold (Tmin) of annual facility case volume to optimize outcomes for patients with resected perihilar cholangiocarcinoma. METHODS: We identified patients with localized perihilar cholangiocarcinoma who underwent resection within the National Cancer Database (2010-2017). We used marginal structural logistic regression models to estimate the average treatment effect of receiving care in facilities meeting/exceeding Tmin on 90-day mortality and other postoperative outcomes. RESULTS: A total of 2471 patients underwent resection for perihilar cholangiocarcinoma at 471 facilities. There was no effect of total hepatopancreatobiliary, surgical hepatopancreatobiliary, total hepatobiliary, surgical hepatobiliary, or total perihilar cholangiocarcinoma case volume on 90-day mortality. A Tmin of seven perihilar cholangiocarcinoma resections/year resulted in lower odds of 90-day mortality (IP-weighted OR = 0.49, 95% CI: 0.66-0.87). A total of two facilities met the Tmin. Patients receiving treatment at Tmin facilities had lower odds of length of stay ≥ 7 days (IP-weighted OR = 0.85, 95% CI: 0.75-0.97) and positive surgical resection margins (IP-weighted OR = 0.40, 95% CI: 0.47-0.55). Additionally, undergoing surgery at Tmin facilities resulted in higher (≥ 4 nodes) lymph node yields (IP-weighted OR = 1.94, 95% CI: 1.21-3.11) but no change in the odds of nodal positivity. There was no effect of undergoing surgery at Tmin facilities on 30-day mortality or re-admission. CONCLUSIONS: Resection of perihilar cholangiocarcinoma is infrequently performed at a high number of facilities. A Tmin of ≥ 7 resections/year resulted in lower 90-day mortality and improved postoperative outcomes. Our data suggest that regionalization of care for patients with perihilar cholangiocarcinoma could potentially improve outcomes in the USA.
BACKGROUND: We determined the minimum threshold (Tmin) of annual facility case volume to optimize outcomes for patients with resected perihilar cholangiocarcinoma. METHODS: We identified patients with localized perihilar cholangiocarcinoma who underwent resection within the National Cancer Database (2010-2017). We used marginal structural logistic regression models to estimate the average treatment effect of receiving care in facilities meeting/exceeding Tmin on 90-day mortality and other postoperative outcomes. RESULTS: A total of 2471 patients underwent resection for perihilar cholangiocarcinoma at 471 facilities. There was no effect of total hepatopancreatobiliary, surgical hepatopancreatobiliary, total hepatobiliary, surgical hepatobiliary, or total perihilar cholangiocarcinoma case volume on 90-day mortality. A Tmin of seven perihilar cholangiocarcinoma resections/year resulted in lower odds of 90-day mortality (IP-weighted OR = 0.49, 95% CI: 0.66-0.87). A total of two facilities met the Tmin. Patients receiving treatment at Tmin facilities had lower odds of length of stay ≥ 7 days (IP-weighted OR = 0.85, 95% CI: 0.75-0.97) and positive surgical resection margins (IP-weighted OR = 0.40, 95% CI: 0.47-0.55). Additionally, undergoing surgery at Tmin facilities resulted in higher (≥ 4 nodes) lymph node yields (IP-weighted OR = 1.94, 95% CI: 1.21-3.11) but no change in the odds of nodal positivity. There was no effect of undergoing surgery at Tmin facilities on 30-day mortality or re-admission. CONCLUSIONS: Resection of perihilar cholangiocarcinoma is infrequently performed at a high number of facilities. A Tmin of ≥ 7 resections/year resulted in lower 90-day mortality and improved postoperative outcomes. Our data suggest that regionalization of care for patients with perihilar cholangiocarcinoma could potentially improve outcomes in the USA.
Authors: Mechteld C de Jong; Hugo Marques; Bryan M Clary; Todd W Bauer; J Wallis Marsh; Dario Ribero; Pietro Majno; Ioannis Hatzaras; Dustin M Walters; Andrew S Barbas; Raquel Mega; Richard D Schulick; Michael A Choti; David A Geller; Eduardo Barroso; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik Journal: Cancer Date: 2012-03-13 Impact factor: 6.860
Authors: Gennaro Nuzzo; Felice Giuliante; Francesco Ardito; Ivo Giovannini; Luca Aldrighetti; Giulio Belli; Fabrizio Bresadola; Fulvio Calise; Raffaele Dalla Valle; Davide F D'Amico; Leandro Gennari; Stefano M Giulini; Alfredo Guglielmi; Elio Jovine; Riccardo Pellicci; Heinrich Pernthaler; Antonio D Pinna; Stefano Puleo; Guido Torzilli; Lorenzo Capussotti; Umberto Cillo; Giorgio Ercolani; Massimo Ferrucci; Laura Mastrangelo; Nazario Portolani; Carlo Pulitanò; Dario Ribero; Andrea Ruzzenente; Vincenzo Scuderi; Bruno Federico Journal: Arch Surg Date: 2012-01
Authors: Jonathan J Hue; Kavin Sugumar; Sarah C Markt; Amr Mohamed; J Eva Selfridge; David Bajor; Luke D Rothermel; Jeffrey M Hardacre; John B Ammori; Jordan M Winter; Lee M Ocuin Journal: Surgery Date: 2020-10-18 Impact factor: 3.982
Authors: O Farges; J M Regimbeau; D Fuks; Y P Le Treut; D Cherqui; P Bachellier; J Y Mabrut; M Adham; F R Pruvot; J F Gigot Journal: Br J Surg Date: 2012-11-02 Impact factor: 6.939
Authors: Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik Journal: Hepatobiliary Surg Nutr Date: 2014-02 Impact factor: 7.293
Authors: Umberto Cillo; Constantino Fondevila; Matteo Donadon; Enrico Gringeri; Federico Mocchegiani; Hans J Schlitt; Jan N M Ijzermans; Marco Vivarelli; Krzysztof Zieniewicz; Steven W M Olde Damink; Bas Groot Koerkamp Journal: Liver Int Date: 2019-05 Impact factor: 5.828
Authors: Matteo Mueller; Eva Breuer; Takashi Mizuno; Fabian Bartsch; Francesca Ratti; Christian Benzing; Noémie Ammar-Khodja; Teiichi Sugiura; Tsukasa Takayashiki; Amelia Hessheimer; Hyung Sun Kim; Andrea Ruzzenente; Keun Soo Ahn; Tiffany Wong; Jan Bednarsch; Mizelle D'Silva; Bas Groot Koerkamp; Heithem Jeddou; Victor López-López; Charles de Ponthaud; Jennifer A Yonkus; Warsan Ismail; Lynn E Nooijen; Camila Hidalgo-Salinas; Elissaios Kontis; Kim C Wagner; Ganesh Gunasekaran; Ryota Higuchi; Ana Gleisner; Chaya Shwaartz; Gonzalo Sapisochin; Richard D Schulick; Masakazu Yamamoto; Takehiro Noji; Satoshi Hirano; Myron Schwartz; Karl J Oldhafer; Andreas Prachalias; Giuseppe K Fusai; Joris I Erdmann; Pål-Dag Line; Rory L Smoot; Olivier Soubrane; Ricardo Robles-Campos; Karim Boudjema; Wojciech G Polak; Ho-Seong Han; Ulf P Neumann; Chung-Mau Lo; Koo Jeong Kang; Alfredo Guglielmi; Joon Seong Park; Constantino Fondevila; Masayuki Ohtsuka; Katsuhiko Uesaka; René Adam; Johann Pratschke; Luca Aldrighetti; Michelle L De Oliveira; Gregory J Gores; Hauke Lang; Masato Nagino; Pierre-Alain Clavien Journal: Ann Surg Date: 2021-11-01 Impact factor: 12.969
Authors: Andrea Ruzzenente; Fabio Bagante; Pim B Olthof; Luca Aldrighetti; Ruslan Alikhanov; Matteo Cescon; Bas Groot Koerkamp; William R Jarnagin; Silvio Nadalin; Johann Pratschke; Moritz Schmelzle; Ernesto Sparrelid; Hauke Lang; Calogero Iacono; Thomas M van Gulik; Alfredo Guglielmi Journal: Ann Surg Oncol Date: 2021-05-06 Impact factor: 5.344